1. Inhibition of DNA synthesis and oncogene expression in tumor cells by the biological factor DIF.
- Author
-
Letnansky K, Vetterlein M, and Shi C
- Subjects
- Animals, Calcium pharmacology, Carcinoma, Ehrlich Tumor genetics, Cell Line, DNA, Neoplasm biosynthesis, DNA, Neoplasm drug effects, Diglycerides pharmacology, Egtazic Acid pharmacology, Gene Expression drug effects, Genes, myc drug effects, Humans, Mice, Protein-Tyrosine Kinases genetics, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-fos, Rats, Rats, Inbred Strains, Sarcoma, Yoshida genetics, Signal Transduction drug effects, Thymidine metabolism, Transcription, Genetic drug effects, Antineoplastic Agents pharmacology, DNA Replication drug effects, Placental Hormones pharmacology, Proto-Oncogenes drug effects
- Abstract
A regulatory factor isolated from the maternal part of bovine placentas (decidua inhibitory factor, DIF) inhibits the incorporation of thymidine into the DNA of a variety of animal and human tumors. The degree of inhibition is dependent on the concentration of the factor. Results indicate that signal transduction occurs via a Ca2+ mobilizing pathway after specific binding of the inhibitor to tumor cell surface receptors. On of the main consequences of DIF action is the inhibition of c-fos and c-myc expression and/or degradation.
- Published
- 1991